Mizuho Securities Keeps Their Hold Rating on Adaptimmune Therapeutics (ADAP)
27 October 2022 - 08:55AM
TipRanks
E ratio of -1.14.
https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-hold-rating-on-adaptimmune-therapeutics-adap-2?utm_source=advfn.com&utm_medium=referral
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Feb 2023 to Mar 2023
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Mar 2022 to Mar 2023